Watch the latest in the series of transatlantic talking heads, a joint collaboration of the Crohn’s & Colitis Foundation and the European Crohn’s & Colitis Organization. When attending conferences and workshops, there seems to be a difference in the recommendations from thought leaders as to what pregnant IBD patients should do about their biologics during pregnancy and post-partum. Joining moderator Christina Ha are panelists Iris Dotan and Uma Mahadevan to discuss whether or not we should stop biologic agents in patients who are pregnant. This program was made possible through an educational grant from UCB.
Abigail J. Meyers, PA-CPeer